Literature DB >> 28152671

Determination of multidirectional myocardial deformations in cats with hypertrophic cardiomyopathy by using two-dimensional speckle-tracking echocardiography.

Ryohei Suzuki1, Yohei Mochizuki1, Hiroki Yoshimatsu1, Takahiro Teshima1, Hirotaka Matsumoto1, Hidekazu Koyama1.   

Abstract

Objectives Hypertrophic cardiomyopathy, a primary disorder of the myocardium, is the most common cardiac disease in cats. However, determination of myocardial deformation with two-dimensional speckle-tracking echocardiography in cats with various stages of hypertrophic cardiomyopathy has not yet been reported. This study was designed to measure quantitatively multidirectional myocardial deformations of cats with hypertrophic cardiomyopathy. Methods Thirty-two client-owned cats with hypertrophic cardiomyopathy and 14 healthy cats serving as controls were enrolled and underwent assessment of myocardial deformation (peak systolic strain and strain rate) in the longitudinal, radial and circumferential directions. Results Longitudinal and radial deformations were reduced in cats with hypertrophic cardiomyopathy, despite normal systolic function determined by conventional echocardiography. Cats with severely symptomatic hypertrophic cardiomyopathy also had lower peak systolic circumferential strain, in addition to longitudinal and radial strain. Conclusions and relevance Longitudinal and radial deformation may be helpful in the diagnosis of hypertrophic cardiomyopathy. Additionally, the lower circumferential deformation in cats with severe hypertrophic cardiomyopathy may contribute to clinical findings of decompensation, and seems to be related to severe cardiac clinical signs. Indices of multidirectional myocardial deformations by two-dimensional speckle-tracking echocardiography may be useful markers and help to distinguish between cats with hypertrophic cardiomyopathy and healthy cats. Additionally, they may provide more detailed assessment of contractile function in cats with hypertrophic cardiomyopathy.

Entities:  

Mesh:

Year:  2017        PMID: 28152671     DOI: 10.1177/1098612X17691896

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  6 in total

1.  Speckle tracking echocardiography in cats with preclinical hypertrophic cardiomyopathy.

Authors:  Ilaria Spalla; Adrian Boswood; David J Connolly; Virginia Luis Fuentes
Journal:  J Vet Intern Med       Date:  2019-04-16       Impact factor: 3.333

2.  Layer-specific myocardial function in asymptomatic cats with obstructive hypertrophic cardiomyopathy assessed using 2-dimensional speckle-tracking echocardiography.

Authors:  Ryohei Suzuki; Yohei Mochizuki; Hiroki Yoshimatsu; Ayaka Niina; Takahiro Teshima; Hirotaka Matsumoto; Hidekazu Koyama
Journal:  J Vet Intern Med       Date:  2018-11-29       Impact factor: 3.333

3.  Assessment of left atrial function in feline hypertrophic cardiomyopathy by using two- dimensional speckle tracking echocardiography.

Authors:  Arisara Kiatsilapanan; Sirilak Disatian Surachetpong
Journal:  BMC Vet Res       Date:  2020-09-18       Impact factor: 2.741

4.  Left and Right Myocardial Functionality Assessed by Two-Dimensional Speckle-Tracking Echocardiography in Cats with Restrictive Cardiomyopathy.

Authors:  Ryohei Suzuki; Yunosuke Yuchi; Haruka Kanno; Takahiro Teshima; Hirotaka Matsumoto; Hidekazu Koyama
Journal:  Animals (Basel)       Date:  2021-05-28       Impact factor: 2.752

5.  Early detection of myocardial dysfunction using two-dimensional speckle tracking echocardiography in a young cat with hypertrophic cardiomyopathy.

Authors:  Ryohei Suzuki; Yohei Mochizuki; Hiroki Yoshimatsu; Ayaka Niina; Takahiro Teshima; Hirotaka Matsumoto; Hidekazu Koyama
Journal:  JFMS Open Rep       Date:  2018-02-08

6.  Assessment of myocardial function in obstructive hypertrophic cardiomyopathy cats with and without response to medical treatment by carvedilol.

Authors:  Ryohei Suzuki; Yohei Mochizuki; Yunosuke Yuchi; Yuyo Yasumura; Takahiro Saito; Takahiro Teshima; Hirotaka Matsumoto; Hidekazu Koyama
Journal:  BMC Vet Res       Date:  2019-10-28       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.